In the realm of advanced biochemical research, the study of molecular interaction mechanisms has become increasingly refined. Among the various tools utilized in laboratory settings, the VCAM 1 binding peptide has garnered significant attention due to its specific affinity for target molecules. As someone who follows developments in peptide synthesis and molecular biology, I have found the technical specifications of this compound to be a fascinating example of how targeted binding can be achieved at a microscopic level.
Understanding the Molecular Architecture
The VCAM1 binding peptide is defined by its specific sequence: VHPKQHRGGSKGC. Th Soluble in pure water. Description,Vascular cell adhesion molecule-1 binding peptide. References, Characterization of VCAM-1-Binding Peptide-Functionalized Read more is sequence is not arbitrary; it is engineered to facilitate high-affinity interactions. When evaluating this compound, one must consider its physical properties. With a molecular weight of approximately 1390.57 and a chemical formula of C57H95N, it represents a precise structural arrangement designed for stability and interaction.
It is worth noting that Vascular cell adhesion molecule-1 binding peptide is typically provided in a lyophilized format. Proper handling is essential, as the user must reconstitute the pellet in distilled water or appropriate buffers to ensure the integrity of the peptide. This Vascular Cell Adhesion Molecule 1 (VCAM1) Peptide is frequently utilized in experiments requiring precise control over binding dynamics.
Functional Mechanisms and Biological Context
To understand why researchers focus on this entity, we must look at VCAM1 (Vascular Cell Adhesion Molecule 1). This protein is a Cell adhesion glycoprotein predominantly expressed on the surface of endothelial cells. In its native state, V Sep 2, 2020—VCAM1 (Vascular Cell Adhesion Molecule 1) is a Protein Coding gene. Diseases associated with VCAM1 include Viral Encephalitis and Chronic Venous Read more CAM 1 is known to regulate leukocyte migration across blood vessel walls, a process that is fundamental to understanding cellular communication.
Interestingly, VCAM1 is expressed at very low levels in ECs under normal physiological conditions but is strongly induced by inflammatory stimuli. This dynamic expression profile is why the VCAM1-binding peptide is such a valuable tool for researchers investigating how VCAM-1 binds to very late antigen-4 (VLA-4) integrin on the cell surface. Because VCAM-1 forms complexes with several binding partners, including alpha-4-beta-1 integrin, having a specific peptide that can facilitate or block these interactions all Mar 3, 2026—Enables integrin binding activity. Involved in several processes, including cellular response to tumor necrosis factor; nervous system development; and Read more ows for granular control in experimental models.
Vascular Cell Adhesion Molecule 1 (VCAM1) Peptide; Format. Lyophilized ; Reconstitution. Reconstitute pellet in distilled water where required. For Blocking Read moreWhy Precision Matters in Research
In my experience reviewing various laboratory reagents, the utility of a VCAM 1 binding peptide often lies in its specificity. Whether it is being used to characterize VCAM1 (CD106) expression in human tissue or to investigate how VCAM-1 via JunB regulates IL-8 promoter activity and expression, the goal remains the same: accuracy.
Furthermore, there is a distinction between functional binding and blocking. Many researchers utilize peptides that bind specifically to the target antibody to confirm the specificity of an assay. For instance, a VCAM-1 Antibody recognizes endogenous levels of total VCAM-1 protein, and using a competing peptide ensures th by G Ailuno·2020·Cited by 28—Thebindingof leukocytes toVCAM-1activates a cascade of intracellular events.VCAM-1activation in endothelial cells induces, within 30 s, a calcium flux Read more at the signal observed is indeed due to the target protein rather than non-specific binding. This is a standard procedure to ensure the reliability of results.
Observations on Emerging Trends
The interest in this area is growing, particularly because VCAM-1 has emerged as a promising drug target for various cardiovascular investigations. As scientists continue to map out how 1 binds to its receptors, the development of synthetic ligands will by X Jia·2022·Cited by 37—These findings established a novel strategy for targeting the NLRP3 inflammasome using NLRP3 siRNA-PCLs to interrupt LDL transcytosis, representing a potential Read more likely become even more sophisticated. Much like how unactivated lymph Previous studies have shown thatunactivated lymphocytes bind to CS1 peptideand that the adhesion of these cells to high endothelium is inhibited by CS1 Read more ocytes bind to CS1 peptide, the ability to mimic these natural in by X Jia·2022·Cited by 37—These findings established a novel strategy for targeting the NLRP3 inflammasome using NLRP3 siRNA-PCLs to interrupt LDL transcytosis, representing a potential Read more teractions allows for the development of highly specific research probes.
By focusing on the VCAM1 pathway, researchers are gaining a deeper understanding of how these molecules enable integrin binding activity. Whether one is studying the VCAM pathways or simply observing the 1 interaction, the use of synthesized peptides remains a cornerstone of modern molecular exploration. The precision offered by the VHPKQHRGGSKGC sequence provides a reliable way to interact with these complex biological systems, ensuring that experimental data remains consistent and reproducible.